The III theme benefits from vital interfaces with core UCL and UCLH infrastructure, including the UCL Institute of Immunity and Transplantation; Royal Free Hospital; and the Centre for Cell and Gene and Tissue Therapy.
Key partners for the III programme include:
Royal Free Hospital
The Royal Free Campus is one UCL Medical School’s main teaching and research sites. Research activity at the Royal Free falling within the III Programme include:
- Centre for Amyloidosis and Acute Phase Proteins
- Centre for Clinical Microbiology
- UCL Institute for Liver and Digestive Health
- Centre for Rheumatology and Connective Tissue Diseases
- Human Challenge Facility (with Imperial College London)
The UCL Institute of Immunity and Transplantation
The Institute of Immunity and Transplantation is an experimental medicine partnership bringing together world-leading research and clinical trials in the newly opened (2021) Pears Building, a multi-million pound, state of the art research centre at the Royal Free Hospital.
Using state of the art experimental platforms in transplantation and tissue engineering, vaccination, cell and gene therapy, the Institute focusses on delivery of novel treatments for cancer, chronic infection, autoimmunity and inherited diseases.
UCLH Hospital for Tropical Diseases
UK Imported Fever Service and Rare and Imported Pathogens Laboratory
BioAID Consortium
Francis Crick Institute
Great Ormond Street Hospital
Translational Research Collaborations
Investigators from the III theme are partners in two of the NIHR Office for Clinical Research Infrastructure (NOCRI) Translational Research Collaborations: Musculoskeletal, Centre Academic Lead (CAL) Professor Mike Ehrenstein; and Respiratory , CAL Professor Joanna Porter. Dr Sarah Watters is the Centre Business Lead for both partnerships.
